A recent study reveals that people who come off blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who end traditional lifestyle plans.
Published data in a prominent health publication shows that while obese individuals can lose substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.
"People using such drugs should be informed of the risk of quick weight regain when the medication is stopped," warns expert Dr. Susan Jebb.
That rate of recovery means a return to starting mass in about one and a half years.
Analyzing Treatments
The analysis, which looked at 37 of trials involving over 9,000 of patients, contrasted the results of the injectable medications with conventional dieting.
Researchers note that people who lose weight through diet and exercise usually see a slower weight regain—approximately 100 grams monthly—once they finish.
The Reason for the Rapid Rebound
Doctors propose the mechanism of the injections is key to understanding the amplified weight return.
The injections copy a natural hormone called GLP-1, which moderates appetite.
"Long-term administration of the hormone levels several times higher than normal could lead to the body to produce less of its endogenous GLP-1, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this hormone supplement leads to appetite is unsuppressed, making excessive eating a significant risk."
A Chronic Disease?
Health authorities recommend the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Professionals say that, given the high risk of weight regain, the therapy might need to be life-long.
This view is supported by drug manufacturers, who state that the findings "underscore the persistent nature of obesity," akin to managing diseases like high blood pressure.
Patient Experiences
People who have stopped the jabs describe a sudden resurgence of hunger.
"I experienced something flipping and you become ravenous," said one woman.
This difficulty is compounded if patients have not adopted permanent dietary or behavioural modifications during therapy.
Significant Adoption
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Use is higher among women than males.
- The middle-aged demographic shows the highest level of interest.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, clinicians stress that while these medications are powerful agents for weight loss, they are not a magic solution and long-term success relies on integrated behavioural changes.
